Committed to providing exceptional care and continued support to patients, families and caregivers.

Menu

NCT02599324

Disease Type: Gastrointestinal
Status: Open

Trial Information

A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors

Click here for more information

This trial is available at:

Methodist Estabrook Cancer Center
8303 Dodge Street, Suite 250, Omaha, NE 68114
Phone: 402-354-8124
Fax: 402-354-8127

For more information, please contact: